SEC Form 4 · accession 0000904454-15-000587

Clovis Oncology, Inc. · CLVS

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Table I — non-derivative securities

Table II — derivative securities

Explanation of responses

• F1Distribution of shares in kind by Domain Partners VII, L.P. to its partners, including 89,649 shares to One Palmer Square Associates VII, LLC, the sole general partner of Domain Partners VII, L.P.
• F2As a managing member of the sole general partner of Domain Partners VII, L.P., the Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by Domain Partners VII, L.P.
• F3As a managing member of the sole general partner of DP VII Associates, L.P., the Reporting Person may also be deemed to indirectly beneficially own 35,506 shares of Common Stock held by DP VII Associates, L.P.
• F4As a managing member of One Palmer Square Associates VII, LLC, the Reporting Person may also be deemed to indirectly beneficially own 89,649 shares of Common Stock held by One Palmer Square Associates VII, LLC.
• F5As a managing member of Domain Associates, LLC, the Reporting Person may also be deemed to indirectly beneficially own 32,760 shares of Common Stock held by Domain Associates, LLC.
• F6Pursuant to Instruction 4(b)(iv) of Form 4, the Reporting Person has elected to report as indirectly beneficially owned the entire number of securities owned by Domain Partners VII, L.P., DP VII Associates, L.P., One Palmer Square Associates VII, LLC and Domain Associates, LLC , however he disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his pecuniary interest therein and/or that are not actually distributed to him.